PULSE BIOSCIENCES, INC. cotiza a 48.54 USD y tiene una capitalización bursátil de $3.5B. En los últimos 12 meses ha facturado $1M con un margen de flujo de caja libre del -15553.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp des…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.28 | $-0.24 | $-0.18 |
| Estimado | $-0.29 | $-0.28 | $-0.22 | $-0.21 |
| Sorpresa | — | +0.0% | -9.1% | +14.3% |
| Métrica | PLSE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -54.0% | 57.0% | -111.0% |
| Operating Margin | -21982.6% | -38.6% | -21944.0% |
| Net Margin | -20794.6% | -33.6% | -20761.0% |
| FCF Margin | -15553.4% | -13.9% | -15539.6% |
| ROE | -90.2% | -40.4% | -49.8% |
| ROA | -77.0% | -32.0% | -45.0% |
| Current Ratio | 10.53 | 2.84 | +7.69 |
| Debt / Equity | — | 0.28 | — |